BN Business News
Add your company to Business Communicator →

Finanse publiczne · 28/09/2011

FDA Corrects Temporary Regulations on Branded Prescription Drug Fee

The US Food and Drug Administration has issued corrections to temporary regulations regarding the annual fee imposed on pharmaceutical companies that manufacture or import branded prescription drugs, as mandated by the Patient Protection and Affordable Care Act.

Source: Federal Register — Department of the TreasuryOpen original release →